Study findings indicate a distinct upregulation of ZIC5 in LUAD relative to LUSC, with adenocarcinoma cases presenting significantly increased ZIC5 expression that specifically associates with adverse survival probabilities. Here, ZIC5 is linked to adenocarcinoma.